Venus Remedies Limited has received Good Manufacturing Practice (GMP) certification from the Ministry of Health of Moldova ...

Neisseria gonorrhoeae, responsible for the sexually transmitted infection gonorrhea, is becoming increasingly difficult to ...

The emergence of Neisseria gonorrhoeae strains resistant to ceftriaxone, the last reliable treatment, poses significant ...

Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of ...

In addition, Innoviva Specialty Therapeutics will purchase its demand of Zevtera drug product from Basilea. Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced ...

Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered ...

a wholly owned subsidiary of Innoviva Inc. (NASDAQ: INVA), for the commercialization of Basilea’s hospital anti-MRSA antibiotic Zevtera® (ceftobiprole) in the United States (US). Innoviva ...

Every year, more than five million people die due to bacterial infections that are becoming increasingly resistant to a range of antibiotics. It is a concern the World Health Organization has ...

At the same time, cephalosporin resistance was also taking over. Today, only one oral antibiotic is left: the macrolide, ...

The best antibiotic to treat pneumonia will depend on several factors, such as your type of pneumonia, age, lifestyle, and medical history. Zithromax (azithromycin) is often the first-line treatment ...